ST Assembly Test Services Ltd said it completed its acquisition of ChipPAC Inc for US$548 million in stock to form a company that will aim to be the world's third-largest provider of chip-testing and packaging services.
\nThe combined firm, STATS ChipPAC Ltd, has factories in Malaysia, China, South Korea, Taiwan and Singapore, where it is based. Customers include Intel Corp and Analog Devices Inc. It forecast third-quarter profit of US$0.05 to US$0.09 per American depositary share (ADS), on sales of US$230 million to US$240 million, in a statement.
\nDemand, however, may not be strong enough for the combined company to use all of its expanded manufacturing capacity, anal-ysts said.
\n"The timing may not be the best if we are going into another industry downturn," said Dharmo Soejanto, an analyst with Kim Eng Securities, who rates the shares "sell." "It means you have a bigger scale and more capacity to fill."
\nMerrill Lynch & Co last month cut its forecast for next year sales growth for the chip industry to 6 percent from 16 percent, saying excess manufacturing capacity may lead to price declines.
\nShareholders of ChipPAC Inc, who earlier approved the transaction in a meeting, will get 0.87 ST Assembly ADS for each share of Fremont, California-based ChipPAC, ChipPAC said in a statement. The company expects cost savings of between US$25 million and US$30 million a year. ST Assembly said it paid 86.19 million ADS to those shareholders.
\nST Assembly said it's making the acquisition to add more customers and manufacturing facilities and to combine Fremont, California-based ChipPAC's skills at packaging chips with its own testing business.
\n"Scale and size, and a more competitive cost structure are the benefits of this merger," said ST Assembly chief executive Tan Lay Koon on a conference call with analysts. "We are going to leverage off our competitive cost structure and we'll enjoy higher margins with more advanced products, and we'll be more competitive with bigger volume."
\nBased on combined sales, STATS ChipPAC will rank behind Advanced Semiconductor Engineering Inc (日月光) and ahead of Siliconware Precision Industries Co (
Just a few years ago, the millennial generation — generally defined as those born from the early 1980s through the mid-1990s — was synonymous with youthful rebellion. However, now, as the millennials ease into early middle age, they are finding their path out of their parents’ basement to be a lot harder than it was for earlier generations. The fundamental problem is that millennials are not building wealth. The wealth of the median US household headed by someone 35 or younger has actually shrunk in inflation-adjusted terms since the mid-2000s, even as the wealth of older Americans has continued to grow. An
‘LITTLE CHOICE’: The airline said it expected only about 8,000 of its 29,000 employees to be working by next month, but hoped to have 21,000 in the next two years Qantas Airways Ltd plans to cut at least 6,000 jobs and keep 15,000 more workers on extended furloughs as Australia’s largest airline tries to survive the coronavirus pandemic. Qantas yesterday announced a plan to reduce costs by billions of dollars and raise fresh capital. The plan includes grounding 100 planes for a year or more and immediately retiring its six remaining Boeing Co 747 planes. Chief executive Alan Joyce said the airline has to become smaller as it braces for several years of much lower revenues. He said the furloughed workers faced a long interruption to their airline careers. “The actions that we’re taking
Apple Inc’s decision to stop using Intel Corp processors in its Mac computers and switching to its own chips might benefit Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and boost Taiwan’s high-tech exports, Australia and New Zealand Banking Group (ANZ) said in a note on Tuesday. The US tech giant announced the “Apple silicon” initiative at its annual Worldwide Developers’ Conference, which started on Monday. The company said the first Mac powered by its own chips would debut by the end of this year and all product lines might shift to the new architecture in the next two years. TSMC is likely to
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price